Published in TB and Outbreaks Week, February 3rd, 1997
The TB test uses IDB's proprietary DNA-based diagnostic system, Cycling Probe Technology (CPT). IDB has also been developing CPT-based culture confirmation tests for two antibiotic resistant bacteria, MRSA and VRE. The TB test uses the same commercial format that has been developed by IDB for the MRSA and VRE tests.
IDB and Dr. Eisenach recently demonstrated the feasibility of detecting the TB organism using IDB's CPT technology with a...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.